Drug Profile
ONO 3805
Alternative Names: ONO RI 3805Latest Information Update: 16 Apr 1998
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Benzamides; Butyrates
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 16 Apr 1998 Discontinued-III for Benign prostatic hyperplasia in Japan (PO)